Achieving proof of concept in drug discovery and development: the role of competition law in collaborations between public research organizations and industry
One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research in order to advance innovations beyond the discovery phase. This book examines a drug discovery and development model, wher...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cheltenham, UK
Edward Elgar Publishing
[2016]
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Zusammenfassung: | One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research in order to advance innovations beyond the discovery phase. This book examines a drug discovery and development model, where the respective expertise of academia and industry are brought together to take promising discoveries through to proof of concept, providing a means to de-risk the drug discovery and development process. Expert author Helen Yu explores integrated drug discovery by analyzing the intersection of intellectual property law and competition law and discusses the role of stakeholders in the efficient translation and commercialization of publically funded research. Considering the transactional risks associated with drug discovery and development, this book advocates for a greater emphasis on contractual freedom and economic efficiency when assessing collaborative partnerships between industry and public research organizations. This standout book bridges the gap between theoretical research and legal practice by providing a research-based applied perspective on university-industry collaborations in drug age 4 of cover. |
| Beschreibung: | Based on author's thesis (doctoral - University of Copenhagen, Faculty of Law, 2010). - Includes bibliographical references (pages 239-263) and index |
| Beschreibung: | xiv, 266 Seiten 24 cm |
| ISBN: | 9781785369384 1785369385 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV044347716 | ||
| 003 | DE-604 | ||
| 005 | 20171115 | ||
| 007 | t | ||
| 008 | 170613s2016 xxu |||| 00||| eng d | ||
| 010 | |a 016942190 | ||
| 020 | |a 9781785369384 |9 978-1-78536-938-4 | ||
| 020 | |a 1785369385 |9 1-78536-938-5 | ||
| 035 | |a (DE-599)BVBBV044347716 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-M382 | ||
| 050 | 0 | |a KJE6191 | |
| 082 | 0 | |a 346.04/8 |2 23 | |
| 100 | 1 | |a Yu, Helen |4 aut | |
| 245 | 1 | 0 | |a Achieving proof of concept in drug discovery and development |b the role of competition law in collaborations between public research organizations and industry |c Helen Yu |
| 264 | 1 | |a Cheltenham, UK |b Edward Elgar Publishing |c [2016] | |
| 300 | |a xiv, 266 Seiten |c 24 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Based on author's thesis (doctoral - University of Copenhagen, Faculty of Law, 2010). - Includes bibliographical references (pages 239-263) and index | ||
| 520 | |a One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research in order to advance innovations beyond the discovery phase. This book examines a drug discovery and development model, where the respective expertise of academia and industry are brought together to take promising discoveries through to proof of concept, providing a means to de-risk the drug discovery and development process. Expert author Helen Yu explores integrated drug discovery by analyzing the intersection of intellectual property law and competition law and discusses the role of stakeholders in the efficient translation and commercialization of publically funded research. Considering the transactional risks associated with drug discovery and development, this book advocates for a greater emphasis on contractual freedom and economic efficiency when assessing collaborative partnerships between industry and public research organizations. This standout book bridges the gap between theoretical research and legal practice by providing a research-based applied perspective on university-industry collaborations in drug age 4 of cover. | ||
| 650 | 4 | |a Politik | |
| 650 | 4 | |a Recht | |
| 650 | 4 | |a Drugs |x Research |x Law and legislation |z European Union countries | |
| 650 | 4 | |a Drug development |x Government policy |z European Union countries | |
| 650 | 4 | |a Drugs |z European Union countries |z Patents | |
| 650 | 4 | |a Antitrust law |z European Union countries | |
| 651 | 4 | |a Europäische Union. Mitgliedsstaaten | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-78536-937-7 |
| 856 | 4 | 2 | |m LoC Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029750596&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029750596 | ||
Datensatz im Suchindex
| _version_ | 1804177586057641984 |
|---|---|
| adam_text | ACHIEVING PROOF OF CONCEPT IN DRUG DISCOVERY AND DEVELOPMENT
/ YU, HELENYYEAUTHOR
: 2016
TABLE OF CONTENTS / INHALTSVERZEICHNIS
. INTRODUCTION
THE PHARMACEUTICAL INDUSTRY AND DRUG DEVELOPMENT MODELS
INTELLECTUAL PROPERTY RIGHTS AND COMPETITION LAW IN COLLABORATIVE DRUG
DEVELOPMENT BETWEEN INDUSTRY AND INTEGRATED DRUG DISCOVERY ORGANIZATIONS
APPLICATION OF COMPETITION LAW TO THE INTEGRATED DRUG DISCOVERY MODEL:
RESEARCH AND DEVELOPMENT BLOCK EXEMPTION REGULATION
APPLICATION OF COMPETITION LAW TO THE INTEGRATED DRUG DISCOVERY MODEL:
TECHNOLOGY TRANSFER BLOCK EXEMPTION REGULATION
ANALYSIS OF COLLABORATION AGREEMENTS BETWEEN INTEGRATED DRUG DISCOVERY
ORGANIZATIONS AND INDUSTRY
7. CONCLUSION AND IMPLICATIONS
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
| any_adam_object | 1 |
| author | Yu, Helen |
| author_facet | Yu, Helen |
| author_role | aut |
| author_sort | Yu, Helen |
| author_variant | h y hy |
| building | Verbundindex |
| bvnumber | BV044347716 |
| callnumber-first | K - Law |
| callnumber-label | KJE6191 |
| callnumber-raw | KJE6191 |
| callnumber-search | KJE6191 |
| callnumber-sort | KJE 46191 |
| ctrlnum | (DE-599)BVBBV044347716 |
| dewey-full | 346.04/8 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 346 - Private law |
| dewey-raw | 346.04/8 |
| dewey-search | 346.04/8 |
| dewey-sort | 3346.04 18 |
| dewey-tens | 340 - Law |
| discipline | Rechtswissenschaft |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03036nam a2200433 c 4500</leader><controlfield tag="001">BV044347716</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20171115 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">170613s2016 xxu |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">016942190</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781785369384</subfield><subfield code="9">978-1-78536-938-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1785369385</subfield><subfield code="9">1-78536-938-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044347716</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">KJE6191</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">346.04/8</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Yu, Helen</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Achieving proof of concept in drug discovery and development</subfield><subfield code="b">the role of competition law in collaborations between public research organizations and industry</subfield><subfield code="c">Helen Yu</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cheltenham, UK</subfield><subfield code="b">Edward Elgar Publishing</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 266 Seiten</subfield><subfield code="c">24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Based on author's thesis (doctoral - University of Copenhagen, Faculty of Law, 2010). - Includes bibliographical references (pages 239-263) and index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research in order to advance innovations beyond the discovery phase. This book examines a drug discovery and development model, where the respective expertise of academia and industry are brought together to take promising discoveries through to proof of concept, providing a means to de-risk the drug discovery and development process. Expert author Helen Yu explores integrated drug discovery by analyzing the intersection of intellectual property law and competition law and discusses the role of stakeholders in the efficient translation and commercialization of publically funded research. Considering the transactional risks associated with drug discovery and development, this book advocates for a greater emphasis on contractual freedom and economic efficiency when assessing collaborative partnerships between industry and public research organizations. This standout book bridges the gap between theoretical research and legal practice by providing a research-based applied perspective on university-industry collaborations in drug age 4 of cover.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">European Union countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield><subfield code="x">Government policy</subfield><subfield code="z">European Union countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="z">European Union countries</subfield><subfield code="z">Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antitrust law</subfield><subfield code="z">European Union countries</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Europäische Union. Mitgliedsstaaten</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-78536-937-7</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">LoC Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029750596&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029750596</subfield></datafield></record></collection> |
| geographic | Europäische Union. Mitgliedsstaaten |
| geographic_facet | Europäische Union. Mitgliedsstaaten |
| id | DE-604.BV044347716 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:50:26Z |
| institution | BVB |
| isbn | 9781785369384 1785369385 |
| language | English |
| lccn | 016942190 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029750596 |
| open_access_boolean | |
| owner | DE-M382 |
| owner_facet | DE-M382 |
| physical | xiv, 266 Seiten 24 cm |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Edward Elgar Publishing |
| record_format | marc |
| spelling | Yu, Helen aut Achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry Helen Yu Cheltenham, UK Edward Elgar Publishing [2016] xiv, 266 Seiten 24 cm txt rdacontent n rdamedia nc rdacarrier Based on author's thesis (doctoral - University of Copenhagen, Faculty of Law, 2010). - Includes bibliographical references (pages 239-263) and index One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research in order to advance innovations beyond the discovery phase. This book examines a drug discovery and development model, where the respective expertise of academia and industry are brought together to take promising discoveries through to proof of concept, providing a means to de-risk the drug discovery and development process. Expert author Helen Yu explores integrated drug discovery by analyzing the intersection of intellectual property law and competition law and discusses the role of stakeholders in the efficient translation and commercialization of publically funded research. Considering the transactional risks associated with drug discovery and development, this book advocates for a greater emphasis on contractual freedom and economic efficiency when assessing collaborative partnerships between industry and public research organizations. This standout book bridges the gap between theoretical research and legal practice by providing a research-based applied perspective on university-industry collaborations in drug age 4 of cover. Politik Recht Drugs Research Law and legislation European Union countries Drug development Government policy European Union countries Drugs European Union countries Patents Antitrust law European Union countries Europäische Union. Mitgliedsstaaten Erscheint auch als Online-Ausgabe 978-1-78536-937-7 LoC Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029750596&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Yu, Helen Achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry Politik Recht Drugs Research Law and legislation European Union countries Drug development Government policy European Union countries Drugs European Union countries Patents Antitrust law European Union countries |
| title | Achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry |
| title_auth | Achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry |
| title_exact_search | Achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry |
| title_full | Achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry Helen Yu |
| title_fullStr | Achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry Helen Yu |
| title_full_unstemmed | Achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry Helen Yu |
| title_short | Achieving proof of concept in drug discovery and development |
| title_sort | achieving proof of concept in drug discovery and development the role of competition law in collaborations between public research organizations and industry |
| title_sub | the role of competition law in collaborations between public research organizations and industry |
| topic | Politik Recht Drugs Research Law and legislation European Union countries Drug development Government policy European Union countries Drugs European Union countries Patents Antitrust law European Union countries |
| topic_facet | Politik Recht Drugs Research Law and legislation European Union countries Drug development Government policy European Union countries Drugs European Union countries Patents Antitrust law European Union countries Europäische Union. Mitgliedsstaaten |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029750596&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT yuhelen achievingproofofconceptindrugdiscoveryanddevelopmenttheroleofcompetitionlawincollaborationsbetweenpublicresearchorganizationsandindustry |